Jo Godden
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 7
-
- Long-Term Effects of COVID-19 4
- Vagus Nerve Stimulation Research 1
Jo Godden
30 papers receiving 4.3k citations
Jo Godden's Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 2.5k
- Applied Microbiology and Biotechnology 169
- Neurology 719
- Critical Care and Intensive Care Medicine 151
- Modeling and Simulation 90
Countries citing papers authored by Jo Godden
This map shows the geographic impact of Jo Godden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Godden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Godden more than expected).
Fields of papers citing papers by Jo Godden
This network shows the impact of papers produced by Jo Godden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Godden. The network helps show where Jo Godden may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 740 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study Hit paper breakdown → | 2021 | 249 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 8 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 9 | 2021 | 161 | |
| 10 | 2021 | 160 | |
| 11 | 2021 | 135 | |
| 12 | 2021 | 119 | |
| 13 | 2022 | 86 | |
| 14 | 2023 | 83 | |
| 15 | 2021 | 75 | |
| 16 | 2021 | 68 | |
| 17 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 18 | 2022 | 64 | |
| 19 | 2021 | 50 | |
| 20 | 2023 | 32 |
About Jo Godden
Jo Godden is a scholar working on Infectious Diseases, Neurology, Applied Microbiology and Biotechnology, Neurology and Genetics, having authored 30 papers that have together received 4.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers), Long-Term Effects of COVID-19 (4 papers), Inflammatory Bowel Disease (2 papers), Antibiotic Use and Resistance (2 papers), Respiratory viral infections research (1 paper), Vagus Nerve Stimulation Research (1 paper) and Nosocomial Infections in ICU (1 paper). The work is most often cited by research in Infectious Diseases (2.5k citations), Applied Microbiology and Biotechnology (169 citations), Neurology (719 citations), Critical Care and Intensive Care Medicine (151 citations) and Modeling and Simulation (90 citations). Jo Godden has collaborated with scholars based in United Kingdom, Australia and Vietnam. Their work appears in journals such as The Lancet, The Lancet Respiratory Medicine, Open Forum Infectious Diseases, Nature Communications and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.